Advertisement

Reactions Weekly

, Volume 1731, Issue 1, pp 52–52 | Cite as

Avelumab/utomilumab

Diabetic ketoacidosis: case report
Case report
  • 8 Downloads

Reference

  1. Atkins PW, et al. Combination avelumab and utomilumab immunotherapy can induce diabetic ketoacidosis. Diabetes and Metabolism 44: 514-515, No. 6, Dec 2018. Available from: URL: http://doi.org/10.1016/j.diabet.2017.05.005 -CanadaCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations